buying $RVPHthis stock is seasonally very good from mid august to November , bought common stock here jus under 0.90 cents
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.11 USD
−39.26 M USD
0.00 USD
39.69 M
About Reviva Pharmaceuticals Holdings, Inc.
Sector
CEO
Laxminarayan Bhat
Headquarters
Cupertino
Website
Founded
2020
FIGI
BBG00LJZ8FW8
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
RVPH - Breakout Imminent?RVPH is within 8 weeks of reporting expected positive P3 results on a drug compound with blockbuster potential.
A great setup - Beautiful triangle formation is complete with a strong base. 200 day MA is easily within range.
RVPH 1WReviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to d
RVPH - Possible Short IdeaRVPH, another possible short idea similar to CGC. Essentially, both charts present a H&S pattern; however, RVPH is not in a supply zone. This affects the strength of my thesis. In all honesty, I see this stock retracing to that 1.83 range I highlighted. No news as of today to justify the 68% rally.
RVPH potential reversal RVPH Doji star may be a start of trend reversal first target 5.50 second 6.50.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RVPH is 1.82 USD — it has increased by 8.54% in the past 24 hours. Watch Reviva Pharmaceuticals Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Reviva Pharmaceuticals Holdings, Inc. stocks are traded under the ticker RVPH.
RVPH stock has risen by 23.61% compared to the previous week, the month change is a 52.14% rise, over the last year Reviva Pharmaceuticals Holdings, Inc. has showed a −64.77% decrease.
We've gathered analysts' opinions on Reviva Pharmaceuticals Holdings, Inc. future price: according to them, RVPH price has a max estimate of 17.00 USD and a min estimate of 12.00 USD. Watch RVPH chart and read a more detailed Reviva Pharmaceuticals Holdings, Inc. stock forecast: see what analysts think of Reviva Pharmaceuticals Holdings, Inc. and suggest that you do with its stocks.
RVPH reached its all-time high on Dec 7, 2020 with the price of 15.10 USD, and its all-time low was 0.53 USD and was reached on Aug 1, 2022. View more price dynamics on RVPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RVPH stock is 9.58% volatile and has beta coefficient of −0.38. Track Reviva Pharmaceuticals Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Reviva Pharmaceuticals Holdings, Inc. there?
Today Reviva Pharmaceuticals Holdings, Inc. has the market capitalization of 82.91 M, it has increased by 24.04% over the last week.
Yes, you can track Reviva Pharmaceuticals Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Reviva Pharmaceuticals Holdings, Inc. is going to release the next earnings report on Mar 24, 2025. Keep track of upcoming events with our Earnings Calendar.
RVPH earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.24 USD resulting in a −2.46% surprise. The estimated earnings for the next quarter are −0.22 USD per share. See more details about Reviva Pharmaceuticals Holdings, Inc. earnings.
Reviva Pharmaceuticals Holdings, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
RVPH net income for the last quarter is −8.37 M USD, while the quarter before that showed −7.86 M USD of net income which accounts for −6.44% change. Track more Reviva Pharmaceuticals Holdings, Inc. financial stats to get the full picture.
No, RVPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 15.00 employees. See our rating of the largest employees — is Reviva Pharmaceuticals Holdings, Inc. on this list?
Like other stocks, RVPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Reviva Pharmaceuticals Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Reviva Pharmaceuticals Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Reviva Pharmaceuticals Holdings, Inc. stock shows the sell signal. See more of Reviva Pharmaceuticals Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.